A Blueprint for Supply Chain Success
A policy framework aims to boost the manufacture of critical drugs in the USA
The Association of Accessible Medicines (AAM) has released the report ‘A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain’ that offers advice on how the Federal Government could create capacity to manufacture critical medicines in the USA and allied countries (1).
Suggestions include the government’s direct engagement with pharma companies to identify opportunities for investment; the FDA’s improved engagement with manufacturers, as well as the agency developing more efficient regulatory processes for the review and approval of pharmaceutical products; and the scale-up of the US Department of Health and Human Services to expand the nation’s supply chain.
- AAM, “A Blueprint for Enhancing the Security of the US Pharmaceutical Supply Chain”, (2020). Available at: https://bit.ly/3d5Rj1t
After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!
